Esther Drent - Concepedia

Author

Esther Drent

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

E Drent, E. Drent, Esther Drent

Publications

974

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Queen Mary University of London University Medical Center Utrecht Amsterdam University Medical Centers Xpand Biotechnology (Netherlands)

About

Esther Drent is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	370
2	Immunology	3	3	370
3	Cell Biology	2	2	85
4	Autoimmunity	1	1	72
5	Cell Signaling	1	1	13

Esther Drent

Publications

937

Citations

H-Index

Page 1

	Year	Citations
A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization Esther Drent, Maria Themeli, Renée Poels, Molecular Therapy Tumor ImmunologyDrug TargetingImmunologyImmunoeditingAffinity Optimization	2017	285
Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma Esther Drent, Richard W.J. Groen, Willy A. Noort, Haematologica	2016	196
Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells Esther Drent, Renée Poels, Ruud Ruiter, Clinical Cancer Research	2019	168
γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs Cordula Gründer, Suzanne van Dorp, Samantha Hol, Blood	2012	84
Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design Esther Drent, Renée Poels, Manon Mulders, PLoS ONE Car T CellsRadiation OncologyCancer ImmunosurveillanceAdaptive Immune SystemMalignant Blood Disorder	2018	72
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma Renée Poels, Esther Drent, Roeland Lameris, International Journal of Molecular Sciences	2021	65
Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis Lisa C. Holthof, Jort J. van der Schans, Afroditi Katsarou, Clinical Cancer Research	2021	54
αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression Josephine G. M. Strijker, Ronja Pscheid, Esther Drent, Journal of Personalized Medicine Immune RegulationImmunologyImmunologic MechanismAntigen ProcessingImmunotherapeutics	2021	13

Page 1